FDA

19°

Weather

YnetGlobal Channels

Sites & Sources

more channels

Contact

FDA

Sex after 65: FDA approves libido-boosting pill for women

US regulators expand approval of Addyi to postmenopausal women; experts say treatment for low sexual desire remains complex, with limited effectiveness and side effects

Tzur Gueta | 12.17.25

Can Israeli medtech grow in the US without relocating? At least one firm plans to help

US-based The Mullings Group opens Israel office, aiming to accelerate Israeli medtech companies’ path to FDA clearance, commercialization and US market scale without forcing founders to relocate

Maayan Hoffman/The Media Line | 12.17.25

FDA plans unusual warning on COVID vaccines; experts sharply criticize move

Agency considering adding a black box warning to COVID vaccines over claims of child deaths, according to CNN; critics say data are undisclosed, process lacks transparency and decision appears politically driven

ynet Global | 12.12.25

Israeli startup QuantalX wins FDA clearance for first-of-its-kind brain function assessment system

The Delphi-MD system, combining magnetic stimulation and EEG, offers real-time, non-invasive brain health insights and sets new US regulatory standard; already in use in Israel and top US research centers, device now being deployed commercially

ynet Global | 11.22.25

Israeli at-home ultrasound tech firm Pulsenmore soars 33% after winning FDA approval

Tel Aviv-based Pulsenmore, developer of the world’s first home ultrasound device for pregnant women, surged 33% after receiving FDA clearance to market its product, paving the way for entry into the American market

Navit Zomer | 11.02.25

Trump administration to link covid shots to child deaths, alarming scientists

Trump officials plan to cite unverified reports tying COVID-19 vaccines to 25 child deaths at a CDC advisory meeting, alarming scientists who warn the shots are safe and protect against severe illness

Ynet Global | 09.12.25

New eye drops approved that restore near vision without reading glasses

The FDA has approved VIZZ, once-daily eye drops that sharpen near vision for millions with age-related presbyopia; Doctors say the treatment reduces side effects seen with earlier drops and could improve quality of life

Tzur Gueta | 08.19.25

Clinical trial finds liver damage in healthy adults taking common CBD doses, often without symptoms; researchers urge regular testing and medical oversight, especially as CBD use grows rapidly despite limited proof of benefits or long-term safety

Tzur Gueta | 07.15.25

US approves at-home cervical cancer test; Israeli pilot programs underway

FDA’s approval of the Teal Wand, a self-sampling HPV test, marks a shift toward accessible cervical cancer screening, with Israeli HMOs piloting similar programs

Tzur Gueta | 05.16.25

שבב להשתלה במוח מתוצרת נוירלינק של אילון מאסק

Cleaning house: Musk fires FDA employees overseeing Neuralink

Cutting comes as part of Musk's U.S. Department of Government Efficiency position aimed at improving processes under Trump's new administration

Oren Rice | 02.18.25

Milk without a cow comes to Israel

Israeli foodtech company Imagindairy, which already has FDA approval, gets go-ahead to market its products in Israel; Company produces protein identical to cow's milk, but without the use of animals, using an environmentally friendly method

Daniela Ginzburg | 11.27.24

Counterfeit diabetes, weight-loss drugs raise alarm after series of fatalities

Reports indicate 10 deaths and over 100 hospitalizations may be linked to counterfeit semaglutide, found in knockoffs of weight-loss drugs like Ozempic; manufacturer warns unregulated versions, not FDA-approved, could endanger public health

Tzur Gueta | 11.09.24

FDA rejects use of MDMA for PTSD

Advisory Committee says it is concerned over allegations of inappropriate sexual behavior during a clinical trial and the potential for severe health risks after taking the drug

News Agencies, Daniel Edelson, New York | 08.11.24

Study reveals presence of toxic metals in tampons

The FDA regulates tampons as medical devices but does not require testing for chemical contaminants

Ynetnews | 07.18.24

Alzheimer drug gets unanimous approval from FDA panel

Lilly's donanemab, Alzheimer's drug benefits outweigh risks in the early stages of the disease although it causes brain swelling and bleeding; the panel finds, clearing the way for a final FDA decision

Reuters | 06.11.24